For example, the studies included in this meta-analysis involved varying the patient profiles, some of which included patients with more advanced metabolic disease conditions, potentially influencing the degree of weight reduction observed
Retrieved from Magkos, F., Fraterrigo, G., Yoshino, J., et al
GLP-1 medications are already influencing how people eat, what they buy, and what they expect from food
Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells
But is there a link between probiotics and GLP-1
[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Anti-obesity activity of human gut microbiota Bacteroides stercoris KGMB02265